Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/arti...9/?tool=pubmed
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids (full - 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869361/
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study (abst – 2010) http://www.cannabis-med.org/studies/...w.php?s_id=313
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. (abst – 2010)http://www.ncbi.nlm.nih.gov/pubmed/20156559
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20434606
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury. (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235339/
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159760/
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/21354467
Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury (abst – 2011)http://www.fasebj.org/cgi/content/me...urcetype=HWCIT
Spinal Cord Injuries Induce Changes of CB1 Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions (abst – 2011)http://www.unboundmedicine.com/medli...in_Conditions_
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/21915768
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/22210507
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord (abst – 2012)http://www.biomedexperts.com/Abstrac...at_spinal_cord
The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22201038
Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22426389
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full – 2013) http://www.jneuroinflammation.com/content/10/1/20
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full – 2013)http://www.lifesciencesite.com/lsj/l...5s_644_648.pdf
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full – 2013) http://www.jneuroinflammation.com/content/10/1/91
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full – 2013) http://www.sciencedirect.com/science...06452213007835
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF - 2013)http://www.eurekaselect.com/107976/article
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23813098
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23981015
Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979158/
Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia (full – 2014)http://www.sciencedirect.com/science...06452213010531
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation (full – 2014) http://www.nature.com/cddis/journal/...s2014364a.html
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (full – 2014)http://www.plosone.org/article/info%...l.pone.0113161
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25064178
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25505583
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full – 2015)http://www.jneuroinflammation.com/co...014-0216-1.pdf
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids (full - 2010)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869361/
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study (abst – 2010) http://www.cannabis-med.org/studies/...w.php?s_id=313
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury. (abst – 2010)http://www.ncbi.nlm.nih.gov/pubmed/20156559
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20434606
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...2/?tool=pubmed
Modulation of inflammatory responses by a cannabinoid-2-selective agonist after spinal cord injury. (full – 2011)http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235339/
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159760/
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/21354467
Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury (abst – 2011)http://www.fasebj.org/cgi/content/me...urcetype=HWCIT
Spinal Cord Injuries Induce Changes of CB1 Cannabinoid Receptor and C-C Chemokine Expression in Brain Areas Underlying Circuitry of Chronic Pain Conditions (abst – 2011)http://www.unboundmedicine.com/medli...in_Conditions_
Cannabidiol-treated Rats Exhibited Higher Motor Score After Cryogenic Spinal Cord Injury (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/21915768
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/22210507
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/arti...0/?tool=pubmed
A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord (abst – 2012)http://www.biomedexperts.com/Abstrac...at_spinal_cord
The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22201038
Specific inhibition of the JNK pathway promotes locomotor recovery and neuroprotection after mouse spinal cord injury (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22426389
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full – 2013) http://www.jneuroinflammation.com/content/10/1/20
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full – 2013)http://www.lifesciencesite.com/lsj/l...5s_644_648.pdf
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full – 2013) http://www.jneuroinflammation.com/content/10/1/91
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full – 2013) http://www.sciencedirect.com/science...06452213007835
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF - 2013)http://www.eurekaselect.com/107976/article
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23813098
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/23981015
Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979158/
Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia (full – 2014)http://www.sciencedirect.com/science...06452213010531
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation (full – 2014) http://www.nature.com/cddis/journal/...s2014364a.html
Protective effects of cannabidiol on lesion-induced intervertebral disc degeneration (full – 2014)http://www.plosone.org/article/info%...l.pone.0113161
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25064178
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25505583
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full – 2015)http://www.jneuroinflammation.com/co...014-0216-1.pdf